Thrombopoietin Receptor Agonists for Treatment Thrombocytopenia in Dengue Fever

Sisilia, Adelina (2023) Thrombopoietin Receptor Agonists for Treatment Thrombocytopenia in Dengue Fever. International Journal of Science and Research (IJSR), 12 (2). pp. 910-911. ISSN 2319-7064

PDF ARTIKEL ADEL.pdf - Published Version Download (124kB)

Abstract

Dengue fever is considered to be the most prevalent mosquito - borne viral disease worldwide and has proven to be life - threatening at times. Thrombocytopenia occurs in mild and severe cases of dengue fever. commonly observed. Severe thrombocytopenia and bleeding episodes with platelet counts well below the normal range are considered fatal consequences of dengue fever requiring appropriate and timely treatment. Thrombopoietin receptor agonists (TPO-RA) play an important role in stimulation thrombus formation. However, traditional meta - analyses have shown conflicting results efficacy of thrombopoietin receptor agonists and placebo. This review is based solely on hypotheses and articles showing a positive response to thrombopoietin receptor agonists (TPO - RA) in dengue fever after web - based searches on various search engines. Furthermore, this review highlights the need for high - quality randomized trials and meta - analyses to demonstrate the safety and efficacy of thrombopoietin receptor agonist (TPO - RA) therapy in patients with dengue - associated thrombocytopenia.

Item Type:	Article
Uncontrolled Keywords:	thrombopoietin receptor agonist; dengue fever; inpatient; viral desease; thrombocytopenia
Subjects:	R Medicine > RS Pharmacy and materia medica
Divisions:	Postgraduate Programs > Master Program in Clinical Pharmacy
Depositing User:	Adelina Sisilia
Date Deposited:	21 Feb 2023 03:42
Last Modified:	21 Feb 2023 03:42
URI:	http://repository.ubaya.ac.id/id/eprint/43425

Actions (login required)

View Item